Shayan, G. (2018). Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationShayan, G. Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationShayan, G. Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.